GIVEN DOUGLAS B 4

4 · ARROWHEAD PHARMACEUTICALS, INC. · Filed Feb 24, 2021

Insider Transaction Report

Form 4
Period: 2021-02-22
Transactions
  • Sale

    Common Stock

    2021-02-22$88.73/sh1,125$99,82113,875 total(indirect: By Trust)
Holdings
  • Common Stock

    119,368
  • Common Stock

    (indirect: By Trust)
    12,500
Footnotes (3)
  • [F1]Represents securities owned directly by Anne Given Trust ("AG Trust"). Mr. Given, as co-trustee of AG Trust, may be deemed to beneficially own the securities owned directly by AG Trust.
  • [F2]Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.
  • [F3]Represents securities owned directly by Katherine Given Ligtenberg Trust ("KGL Trust"). Mr. Given, as co-trustee of KGL Trust, may be deemed to beneficially own the securities owned directly by KGL Trust.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION